R. De Toni
University of Padua
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by R. De Toni.
Journal of Hypertension | 1995
Paolo Palatini; Gianrocco Graniero; Cristina Canali; Massimo Santonastaso; Lucio Mos; D. Piccolo; D. D'este; Giuseppe Berton; Giuseppe Zanata; G. De Venuto; E. Cozzutti; E. Ferrarese; L. Milani; R. De Toni; L. Nicolosi; P. Visentin; Achille C. Pessina
Objective To study the relationship of urinary albumin excretion to ambulatory blood pressure and other cardiovascular risk factors in borderline to mild hypertension. Patients and methods We studied 779 patients with borderline to mild hypertension (mean±SEM age 33±0.3 years; mean±SEM office blood pressure 146±0.4/94±0.2 mmHg) at 17 hypertension clinics in northeast Italy. Office and 24-h blood pressures were recorded with simultaneous urine collection for albumin measurement. In 510 subjects, left ventricular mass was measured by echocardiography. Results Subjects with overt (>30 mg/24 h) and borderline (16–29 mg/24 h) microalbuminuria had similar 24-h blood pressure levels, higher than those in the subjects without microalbuminuria. In the univariate and multiple regression analyses the albumin excretion rate was closely correlated with 24-h systolic blood pressure and not related to age, body mass index, metabolic parameters, lifestyle factors and degree of left ventricular hypertrophy. Conclusions Borderline values of urinary albumin excretion (16–29 mg/24 h) may be clinically relevant in subjects with borderline to mild hypertension. Renal and cardiac damage do not develop in parallel in the initial phases of hypertension.
Journal of Hypertension | 2010
Paolo Palatini; Guido Garavelli; A Bortolazzi; Lucio Mos; Massimo Santonastaso; O Vriz; R. De Toni; G Maraglino
Objective: Increased sympathetic activity has been found to predict body weight (BW) gain. We did a prospective study to investigate whether clinic heart rate (HR) and 24 h ambulatory HR assessed at baseline and changes in heart rate during follow-up were independent predictors of subsequent increase in BW. Design and Methods: The study was conducted in a cohort of 1008 white stage 1 hypertensive subjects from the HARVEST never treated for hypertension and followed-up for an average of 7 years. Clinic heart rate was the average of 6 readings. Ambulatory heart rate was obtained in 701 subjects. Data were adjusted for baseline body mass index, blood pressure, age, gender, physical activity habits, parental hypertension, cigarette smoking, and alcohol consumption. Results: At the baseline, clinic heart rate was 74.7 ± 9.7 bpm and body mass index was 25.4 ± 3.4 Kg/m2. During the follow-up BW increased by 2.1 ± 7.2 Kg. Both clinic HR (p = 0.005) and 24 h HR (p = 0.02) were significant predictors of BW gain. Also changes in HR measured in the clinic (p = 0.005) or with 24 h recording (p = 0.004) during the follow-up were independent associates of BW gain. In multivariable Cox regression, baseline body mass index (p < 0.001), male gender (p < 0.001), systolic blood pressure (p = 0.01), baseline clinic HR (p = 0.02) and follow-up changes in clinic HR (p < 0.001) were independent predictors of overweight at the end of the follow-up. Subjects with persistent tachycardia (heart rate > = 80 bpm) but not transient tachycardia had a 40% increase in the adjusted risk of overweight in comparison with subjects with normal heart rate (p = 0.02). In the subgroup of subjects with ambulatory HR data, clinic HR remained a significant predictor of subsequent BW gain (p = 0.008) whereas 24 h HR was excluded from the model. Conclusions: Baseline clinic HR and HR changes during the follow-up are independent predictors of BW gain in young persons screened for stage 1 hypertension suggesting that sympathetic nervous system activity may play a role in the development of obesity in hypertension.
Journal of Hypertension | 2010
Giuseppe Berton; Rocco Cordiano; R. Palmieri; Fiorella Cavuto; G.L. Guarnieri; C De Longhi; P Buttazzi; M Centa; R. De Toni; Paolo Palatini
Conclusion: highest and lowest BP values during follow-up after AMI, and chiefly their interaction are associated to higher 10-year mortality.
Archive | 2003
E. De Toni; Giulia Perini; Liliana Chemello; Daniela Mapelli; Elisabetta Bernardinello; F. Del Piccolo; Luisa Cavalletto; C Bergamelli; Raffaella Costanzo; F Bergamaschi; R. De Toni; Angelo Gatta; Carlo Umiltà; Alfredo Alberti; Piero Amodio
No systematic investigation of the cognitive effects of interferon (IFN) therapy in patients with chronic viral hepatitis has been reported. We have conducted a study to assess the cognitive and neurophysiological effects of alpha-IFN.
Kidney International | 2006
Paolo Palatini; Paolo Mormino; Francesca Dorigatti; Massimo Santonastaso; Lucio Mos; R. De Toni; M. Winnicki; M. Dal Follo; Tiziano Biasion; Guido Garavelli; Achille C. Pessina
European Heart Journal | 2001
G Berton; Rocco Cordiano; R. Palmieri; F. Cucchini; R. De Toni; Paolo Palatini
Clinical Science | 1997
G.P. Rossi; Edoardo Pavan; Matteo Chiesura-Corona; Michael Bader; G. Paganini; Maurizio Cesari; R. De Toni; Gianpietro Feltrin; Detlev Ganten; Achille C. Pessina
Diabetologia | 2004
Giuseppe Berton; Rocco Cordiano; R. Palmieri; R. De Toni; G.L. Guarnieri; Paolo Palatini
Psychopathology | 1986
Diego De Leo; Claudio Pellegrini; Laura Serraiotto; Guido Magni; R. De Toni
Journal of Hypertension | 2004
Chiara Ganzaroli; Diego Miotto; R. De Toni; Achille C. Pessina; G.P. Rossi